Skip to Main Content

Artificial Intelligence and Health Law

This Hub page includes AHLA educational events, publications, and other resources pertaining to artificial intelligence and health care.

AHLA AI and Health Law Convener 

AHLA hosted a virtual convener on AI and Health Law on November, 2, 2020. The meeting brought together more than a dozen thought leaders including regulators, clinicians, private practitioners, and other leading authorities for an in-depth discussion of AI in health care. Although AHLA conveners are closed to the public and press to ensure a full and open dialogue among invited stakeholders, the main perspectives and themes from the discussion will be summarized and consolidated into a white paper that will be distributed to convener attendees, AHLA leaders and members, and the public in Spring 2021.

Convener Participants

  • Elise Anthony, Executive Director of Policy, HHS Office of the National Coordinator for Health Information Technology
  • Daniel Barth-Jones, Assistant Professor of Clinical Epidemiology, Columbia University Mailman School of Public Health
  • Elisabeth Belmont, Corporate Counsel, MaineHealth
  • Stephanie Cason, Product Counsel, Google Health
  • Glenn Cohen, James A. Attwood and Leslie Williams Professor of Law, Harvard Law School, Faculty Director, Petrie-Flom Center for Health Law Policy, Biotechnology & Bioethics
  • Nathan Leong, Senior Attorney, Director US Health & Life Sciences, Microsoft
  • Michael Lipinski, Division Director of Federal Policy & Regulatory Affairs, HHS Office of the National Coordinator for Health Information Technology
  • Belinda Luu, Leader of Enterprise Data Management and Governance; Senior Counsel at Kaiser Foundation Health Plan
  • Ryan Mehm, Federal Trade Commission, Division of Privacy and Identity Protection
  • Bakul Patel, Director, Division of Digital Health, FDA
  • Nicholson Price, University of Michigan School of Law
  • Jack Resneck Jr., MD, Immediate Past Chair, Board of Trustees, American Medical Association
  • Ingrid Vasiliu-Feltes, MD, Chief Quality and Innovation Officer, MEDNAX

Convener Planning Workgroup/Moderators

  • Bernadette Broccolo, McDermott Will & Emery LLP
  • Leeann Habte, Best Best & Krieger LLP
  • Jackie Olson, Apple
  • Kristen Rosati, Coppersmith Brockelman PLC
  • Alaap Shah, Epstein Becker & Green PC

Topics for Discussion

The following resources are organized according to the topics that will be discussed at the AI and Health Law Convener.

I. Overview of AI's Current and Emerging Role in Health Care

II. Use of Data in AI

III. Regulating Development and Use of AI

IV. Liability Issues

V. Contracts for Development of AI/Intellectual Property Issues


AI and Health Law On-Demand Webinar Series

Artificial intelligence is poised to become a transformational force in health care. There are nearly endless opportunities to leverage technology to deploy more precise, efficient, and impactful interventions at exactly the right moment in a patient’s care. Inevitably, health law will have to respond to these changes. This four-part webinar series includes in-depth discussions of some of the key legal issues that arise with AI in health care.

Register for the individual on-demand sessions: